Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Service Tax Service Tax + AT Service Tax - 2023 (10) TMI AT This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2023 (10) TMI 998 - AT - Service Tax


Issues Involved:
1. Whether the services rendered by the respondents qualify as "export of services" under Rule 3(1)(c) of Export of Service Rules, 2005.
2. Whether the condition of "used outside India" is satisfied.
3. Whether the payments made to a third party affect the qualification as "export of services."
4. Whether the extended period for demand and penalty is applicable.

Summary:

Issue 1: Qualification as "Export of Services"
The respondents, M/s Glaxo SmithKline Asia Private Limited, provided "Business Support Services" and "Manpower Recruitment and Supply Services" to M/s SmithKline Beecham Plc. (SB Plc), U.K. Revenue contended that these services did not qualify as "export of services" under Rule 3(1)(c) of Export of Service Rules, 2005, and issued a show-cause notice demanding service tax. The Commissioner of Central Excise, New Delhi, dropped the proceedings, leading Revenue to appeal.

Issue 2: Condition of "Used Outside India"
The Department argued that the condition of "used outside India" was not satisfied as the services were performed in India. They relied on Board's Circular No.141/10/2011-TRU dated 13.05.2011, stating that the benefit accrued outside India did not fulfill the requirement of being "used outside India." The respondents countered that the services were used by SB Plc, U.K., and the benefit accrued outside India, supported by Board's Circular No.111/5/2009-ST dated 24.02.2009 and several judicial precedents.

Issue 3: Payments to Third Party
The Department claimed that payments made to a third party indicated that services were consumed in India. The respondents clarified that payments routed through M/s Glaxo SmithKline Services, Unlimited, UK, did not alter the fact that services were used by SB Plc, U.K. The Tribunal agreed, noting that the contractual agreement and the submission of clinical trial reports to SB Plc, U.K., demonstrated that services were used outside India.

Issue 4: Extended Period and Penalty
The respondents argued that the extended period for demand could not be invoked as they regularly filed ST-3 Returns and believed in good faith that their services qualified as exports. The Tribunal found no grounds for extended demand or penalty since the services were deemed to be export services.

Conclusion:
The Tribunal concluded that the services rendered by the respondents to SB Plc, U.K., constituted export of services as they were utilized by a company situated outside India and used outside India. The Tribunal upheld the Commissioner's order, dismissing the Department's appeal. The impugned order was found to be proper and legally sustainable.

(Pronounced on 20/10/2023)

 

 

 

 

Quick Updates:Latest Updates